Bone Marrow Mesenchymal Stromal Cells-derived Extracellular Vesicles therapy(Royan Institute)

N/A

Report date: 2024/01/12 20:08:48

Base Information

Drug NameBone Marrow Mesenchymal Stromal Cells-derived Extracellular Vesicles therapy(Royan Institute)

Drug Alias NameN/A

ClassificationBiologics > Extracellular VesiclesCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsPrimary Ovarian Insufficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIran

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRoyan Institute

China Registration ClassN/A

Develop Information

Active CompaniesRoyan Institute

Inactive CompaniesN/A

Active IndicationsPrimary Ovarian Insufficiency

Inactive IndicationsN/A

Other Information

ATC CodeN/A